SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-21-200535
Filing Date
2021-06-25
Accepted
2021-06-25 17:01:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d105755dsc13da.htm SC 13D/A 39030
  Complete submission text file 0001193125-21-200535.txt   40447
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
CATABASIS PHARMACEUTICALS INC (Subject) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88910 | Film No.: 211048808
SIC: 2834 Pharmaceutical Preparations

Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 646-205-5300
Xontogeny, LLC (Filed by) CIK: 0001844296 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A